Thomas Wisniewski MD
Neurodegenerative, Dementia & Geriatrics
Lulu P. and David J. Levidow Professor of Neurology, Department of Neurology Professor, Department of Pathology Professor, Department of Psychiatry Director, Alzheimer's Disease Center Director, Pearl I. Barlow Center for Memory Evaluation and TreatmentAssoc Chair for Research, Department of Neurology NYU Neurology Associates NYU Pearl Barlow Center for Memory Evaluation and Treatment
Join to View Full Profile
145 E 32nd StFl 2New York, NY 10016
Phone+1 212-263-3210
Fax+1 212-263-3273
Dr. Wisniewski is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Thomas Wisniewski, MD, based in New York, specializes in neurology with subspecialties in neurodegenerative diseases, dementia, and geriatrics. He completed his medical education at King's College London and furthered his training through internships, residencies, and fellowships in New York. Dr. Wisniewski has held multiple key positions at NYU Langone Health, serving as Director at various centers focused on cognitive neurology and Alzheimer's disease. His experience spans areas such as general neurology and cerebrovascular disorders, and he has published extensively in notable journals. He has received prestigious awards, including the ANA Award for Clinical and Scientific Excellence and the Casimir Funk Award.
Education & Training
New York Presbyterian Hospital (Columbia Campus)Fellowship, Neuropathology, 1989 - 1990- New York Presbyterian Hospital (Columbia Campus)Residency, Pathology-Anatomic and Clinical, 1988 - 1989
NYU Grossman School of MedicineResidency, Neurology, 1985 - 1988
SUNY Downstate Health Sciences UniversityInternship, Transitional Year, 1984 - 1985
(King's College London - School of Medicine)Class of 1982
Certifications & Licensure
NY State Medical License 1987 - 2028
American Board of Pathology Neuropathology
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- ANA Award for Clinical and Scientific Excellence – Career Based Contributions over 15 years American Neurological Association, 2023
- Casimir Funk Award in the Natural Sciences Polish Institute of Arts and Sciences of America, 2023
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
Publications & Presentations
PubMed
- Amygdala microstructural changes in subjective cognitive decline: A diffusion kurtosis and neurite orientation dispersion and density imaging study.Ryn Flaherty, Yu Veronica Sui, Arjun V Masurkar, Zakia Ben Youss, Thomas Wisniewski
Journal of Alzheimer's Disease. 2026-07-01 - Multiomics and proteomic insights into Alzheimer's disease biology in Down syndrome.Mitchell Marta-Ariza, Thomas Wisniewski
Expert Review of Neurotherapeutics. 2026-06-29 - Corrigendum to 'Role of CD40 in prion disease and the immune response to recombinant PrP' [Journal of Neuroimmunology 257 (2013) 21-27/475655].Richard Rubenstein, Allen Chiu, Binggong Chang, Thomas Wisniewski
Journal of Neuroimmunology. 2026-06-23
Journal Articles
- Blocking the Apolipoprotein E/Amyloid Beta Interaction in Triple Transgenic Mice Ameliorates Alzheimer's Disease Related Amyloid Betaeta and Tau PathologyLiu S, Breitbart A, Sun Y, Mehta PD, Boutajangout A, Scholtzova H, Wisniewski T, Journal of Neurochemistry, 1/1/2014
- Two Phase 3 Trials of Bapineuzumab in Mild to Moderate Alzheimer's DiseaseSalloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloskavsk..., New England Journal of Medicine, 1/1/2014
- Nerve Growth Factor Metabolic Dysfunction in Down's Syndrome Brains: a Cause for Cholinergic Degeneration?Iulita MF, Carmo SD, Ower A, Fortress A, Aguilar LF, Hanna M, Wisniewski T, Granholm AC, Buhusi M, Busciglio J, Cuello AC, Brain, 1/1/2014
Books/Book Chapters
Other
- Mad Cow Disease and Variant Creutzfeldt-Jakob DiseaseWisniewski T, eMedicine Neurology
http://www.emedicine.com/neuro
1/1/2004 - Prion Related DiseasesWisniewski T, eMedicine Neurology
http://www.emedicine.com/neuro/topic662.htm
1/1/2002
Press Mentions
How Old Is Your Brain? The Answer Might Be Able to Predict Your Life Span, According to a Stanford University StudyJuly 9th, 2025- What Is the Brain Fog That Affects Covid-19 Patients?July 23rd, 2022
- Is Long COVID a Syndrome or a Series of Coronavirus Complications? What We Know Now About Lingering SymptomsJanuary 25th, 2022
Grant Support
- The role of immune deregulation and NGF dysmetabolism in the development of Alzheimer disease in individuals with Down syndromeUNIVERSITY OF CALIFORNIA-IRVINE2024–2029
- Multi-scale and multi-modality imaging of neuropathology in VCIDNEW YORK UNIVERSITY SCHOOL OF MEDICINE2023–2028
- Tools and Resources to Understand Pathophysiology with Post-Mortem Studies of in vivo Neuroimaging Findings in AD and ADRDNEW YORK UNIVERSITY SCHOOL OF MEDICINE2026–2027
- ARIA Pathophysiology Characterized by in vivo Neuroimaging, Plasma Biomarkers and Post-Mortem ProteomicsNEW YORK UNIVERSITY SCHOOL OF MEDICINE2025–2027
- Alzheimer’s Disease Related Biomarkers following SARS-CoV-2 InfectionNEW YORK UNIVERSITY SCHOOL OF MEDICINE2022–2027
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
